Philippines
Participating institutions
- De La Salle Medical and Health Sciences Institute (DLSMHSI)
- Research Institute for Tropical Medicine (RITM-NTRL)
- University of the Philippines Manila (UP-NIH)
Lead investigator
- Charles Yu, MD, MSc (DLSMHSI)
Co-investigators
- Ramon Basilio, MD (RITM-NTRL)
- Victoria Dalay, MD (DLSMHSI)
- Raul Destura, MD (UP-NIH)
- Dodge Lim (RITM-NTRL)
- Roeus Vincent Arjay Reyes (RITM-NTRL)
Staff
- Danaida (Naida) Marcelo, Study Coordinator
- Joseph Edwin Bascuna (NTRL), Medical Technologist
- Gabriela Castillon, Study Nurse
- Camille Felizardo, Medical Technologist
- Mary Faith Franco, Medical Technologist
- Eleonor Garcia, Research Assistant
- Maria Marissa Golla, Medical officer
- Janine Ikan, Research Assistant for DCE Substudy
- Leonedy Masangcay, Medical Technologist
- Angelita Pabruada, Senior Medical Technician
- Laarean Perlas, Study Nurse
- Maria Guileane Pogosa (NTRL), Medical Technologist
- Annalyn (Anna) Reyes, Quality officer
- Maricef (Mariz) Tonquin, Finance officer
- Cherry Ann Villarin, Research Assistant/Medical Technologist
As of April 2024
Cohort enrollment capacity
- Adults with presumptive TB
- Children with presumptive TB
- People with diabetes
- Drug-resistant TB
Number | Rate per 100,000 population | |
---|---|---|
Total TB incidence | 737,000 (390,000 – 1,220,000) | 638 (337 – 1060) |
HIV-positive TB incidence | 14,000 (5,600 – 27,000) | 12 (4.8 – 23) |
MDR/RR-TB incidence | 31,000 (12,000 – 49,000) | 27 (11 – 43) |
HIV-negative TB mortality | 39,000 (36,000 – 43,000) | 34 (31 – 37) |
HIV-positive TB mortality | 800 (730 - 860) | 0.69 (0.63 – 0.75) |